Science

Global Artificial Intelligence (AI) in Drug Discovery Market 2021 Future Growth Explored in Latest Research Report by 2027, key players-NVIDIA Corporation, IBM Corporation, Atomwise, Inc., DEEP GENOMICS, Cloud Pharmaceuticals

A world class Artificial Intelligence (AI) in Drug Discovery market report is the outcome of persistent efforts lead by knowledgeable forecasters, innovative analysts and brilliant researchers who carries out detailed and diligent research on different markets, trends and emerging opportunities in the consecutive direction for the business needs. A systematic investment analysis is also underlined in this report which forecasts impending opportunities for the market players. The report makes organization up to date with the profound knowledge of the global, regional and local market statistics. Businesses can successfully utilize the data, statistics, research, and insights about the healthcare IT industry included in the large scale Artificial Intelligence (AI) in Drug Discovery market report to make decisions about business strategies and to achieve maximum return on investment (ROI).

Artificial intelligence (AI) in drug discovery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3,932.87 million by 2027 growing at a CAGR of 40.5% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits of artificial intelligence has been directly impacting the growth of the market.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-artificial-intelligence-ai-in-drug-discovery-market&kb

The major players covered in the artificial intelligence (AI) in drug discovery market report are Microsoft, NVIDIA Corporation, IBM Corporation, Atomwise, Inc., DEEP GENOMICS, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI   Ltd, Exscientia, Cyclica Inc., Numerate, NuMedii, Inc., Envisagenics., twoXAR, Incorporated, OWKIN, INC., XtalPi Inc., BERG LLC, among other domestic and global players. 

How will this Market Intelligence Report Benefit You?

  1. The report offers statistical data in terms of value (US$) as well as Volume (units) till 2027.
  2. Exclusive insight into the key trends affecting the Artificial intelligence (AI) in drug discovery industry, although key threats, opportunities and disruptive technologies that could shape the Global Artificial intelligence (AI) in drug discovery Market supply and demand.
  3. The report tracks the leading market players that will shape and impact the Global Artificial intelligence (AI) in drug discovery Market most.
  4. The data analysis present in the Artificial intelligence (AI) in drug discovery report is based on the combination of both primary and secondary resources.
  5. The report helps you to understand the real effects of key market drivers or restrainers on Artificial intelligence (AI) in drug discovery business.

Global Artificial Intelligence (AI) in Drug Discovery Market Scope and Market Size

Artificial intelligence (AI) in drug discovery market is segmented on the basis of offering, technology, drug type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on offering, artificial intelligence (AI) in drug discovery market is segmented into software and services.
  • On the basis of technology, artificial intelligence (AI) in drug discovery market is segmented into machine learning and other technologies. Machine learning has been further segmented into deep learning, supervised learning, reinforcement learning, unsupervised learning and other machine learning technologies.
  • Based on drug type, artificial intelligence (AI) in drug discovery market is segmented into small molecule and large molecules.
  • On the basis of application, artificial intelligence (AI) in drug discovery market is segmented into immuno-oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases and other applications.
  • Artificial intelligence (AI) in drug discovery market has also been segmented based on the end user into pharmaceutical & biotechnology companies, contract research organizations, research centres and academic & government institutes.

Enquire Here Get customization & check discount for report @: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-artificial-intelligence-ai-in-drug-discovery-market&kb

Global Artificial Intelligence (AI) in Drug Discovery Market Drivers:

The growing awareness amongst the physicians and patients regarding the benefits of artificial intelligence has been directly impacting the growth of the market.

Increasing need to reduce cost and drug discovery along with reduce time, growth of pharmaceutical industries by collaborations with other industries, adoption of cloud based services and applications, delay in patent expiry are some of the factors that will enhance the growth of artificial intelligence (AI) in drug discovery market in the forecast period of 2020-2027.

On the other hand, expansion of biotechnology industries will further create new and ample opportunities for the growth of artificial intelligence (AI) in drug discovery market in the above mentioned forecast period.

Unavailability of skilled labour and lack of data sets are acting as market challenges for the growth of artificial intelligence (AI) in drug discovery in the above mentioned forecast period.

Table of Contents:

1 Introduction

2 Research Methodologies

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Compliance in Artificial Intelligence (AI) in Drug Discovery Market

8 Artificial Intelligence (AI) in Drug Discovery Market, By Service

9 Artificial Intelligence (AI) in Drug Discovery Market, By Deployment Type

10 Artificial Intelligence (AI) in Drug Discovery Market, By Organization Size

11 Artificial Intelligence (AI) in Drug Discovery Market Analyses, By Vertical

12 Geographic Analyses

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

13 Competitive Landscapes

14 Detailed Company Profiles

15 Related Reports

Request for Detailed TOC:  https://www.databridgemarketresearch.com/toc/?dbmr=global-health-insurance-market&kb

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

Back to top button